Rare Kidney Stone Consortium (RSKC)
United States of America (USA)
1 September 2018 - 31 August 2019
Research collaboration: Rare Kidney Stone Consortium (RSKC) is a research collaboration whose article contributions are accrued to its participating partner institutions.
Rare Kidney Stone Consortium (RSKC)
Partner Institutions
Rare Kidney Stone Consortium (RSKC) is a research collaboration whose article contributions are accrued to its participating partner institutions below.
- Mayo Clinic, United States of America (USA)
- Wake Forest School of Medicine (WFSM), WFU, United States of America (USA)
- NYU School of Medicine, United States of America (USA)
- School of Medicine, CU Anschutz, United States of America (USA)
- Ann and Robert H. Lurie Children's Hospital of Chicago, NU, United States of America (USA)
- The University of Chicago (UChicago), United States of America (USA)
- New York Medical College (NYMC), United States of America (USA)
- University of California, Davis (UC Davis), United States of America (USA)
- Harvard Medical School (HMS), United States of America (USA)
- Landspitali - The National University Hospital of Iceland, Iceland
- University of Padova (UNIPD), Italy
- VU University Amsterdam, Netherlands
- McGill University, Canada
- University Hospital of Cologne, Germany
- University of Bonn (Uni Bonn), Germany
- University of Barcelona (UB), Spain
